|
|
|
|
Polyphenon Pharma welcomes collaboration with companies considering pharmaceutical
development using tea catechins. We are an ideal partner for companies with an interest in:
- Licensing Polyphenon E® for use in indications for which clinical trials are ongoing;
- Collaborating with Polyphenon Pharma to explore new therapeutic uses of Polyphenon E; and
- Exploring the combination of Polyphenon E with their own technology (formulation, device, etc.).
Potential partners will want to consider that Polyphenon E, uniquely:
- Has been approved by the FDA as a pharmaceutical active
- Is manufactured under GMP in a FDA inspected site
- Is accompanied by a comprehensive pre-clinical animal toxicology package
- Is being used in numerous ongoing human clinical studies
- Can be tested in human clinical studies with a short lead time
|
